PointState Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-6,600
| Closed | -$581K | – | 121 |
|
|
2019
Q1 | $581K | Buy |
+6,600
| New | +$581K | 0.01% | 100 |
|
|
2018
Q3 | – | Sell |
-64,900
| Closed | -$6.38M | – | 153 |
|
|
2018
Q2 | $6.38M | Buy |
+64,900
| New | +$6.38M | 0.07% | 103 |
|
|
2016
Q1 | – | Sell |
-525,000
| Closed | -$29.7M | – | 101 |
|
|
2015
Q4 | $29.7M | Sell |
525,000
-62,662
| -11% | -$3.54M | 0.75% | 25 |
|
|
2015
Q3 | $23.4M | Sell |
587,662
-1,697,638
| -74% | -$67.5M | 0.65% | 30 |
|
|
2015
Q2 | $109M | Sell |
2,285,300
-348,100
| -13% | -$16.6M | 1.28% | 19 |
|
|
2015
Q1 | $105M | Buy |
2,633,400
+1,883,400
| +251% | +$74.8M | 1.41% | 19 |
|
|
2014
Q4 | $16.8M | Buy |
+750,000
| New | +$16.8M | 0.29% | 67 |
|
|
2013
Q4 | – | Sell |
-500,000
| Closed | -$5.66M | – | 155 |
|
|
2013
Q3 | $5.66M | Sell |
500,000
-625,000
| -56% | -$7.08M | 0.1% | 91 |
|
|
2013
Q2 | $15.1M | Buy |
+1,125,000
| New | +$15.1M | 0.26% | 67 |
|